In a development that could rewrite the playbook for Indian pharmaceutical companies on the global stage, Sun Pharmaceutical Industries is reportedly preparing a binding all cash offer of around $12 billion to acquire U.S. based Organon & Co.
In a shocking development that has sent ripples across India’s pharmaceutical landscape, Rajasthan’s drug control authorities have issued a statewide alert over a popular antibiotic. Laboratory tests revealed that a widely distributed batch of Qcepod 200 (Cefpodoxime Proxetil 200 mg tablets) contained no active ingredient at all.
Read MoreGlenmark Pharmaceuticals made headlines by appointing Kamlesh Gupta as its new Business Head. A move that is already generating considerable buzz across industry circles, LinkedIn networks, and healthcare news portals.
Read MoreRising tensions in the Middle East are threatening Indian pharmaceutical exports worth up to ₹5,000 crore. Shipping disruptions, rising freight costs, and unstable maritime routes could impact medicine supply to Gulf countries. The situation highlights the vulnerability of global pharma supply chains and the importance of stable trade routes.
Read More
